Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Ozlem Gul

Department of Infectious Disease and Clinical Microbiology, Erzincan Binali Yildirim University, Erzincan, Turkey

  • Research Article   
    Level of SARS-CoV-2 IgG Antibodies after a Single Dose CoronaVac Vaccine: Primarily Report
    Author(s): Umut Devrim Binay*, Faruk Karakecili, Orcun Barkay, Ozlem Gul and Cuma Mertoglu

    Background: It is necessary to use an effective vaccine to end the COVID-19 pandemic. CoronaVac vaccine is used in our country and we aimed to examine the level of antibody development after the first dose. Methods: This is a retrospective, cross-sectional research. The data of the people, who applied to a university hospital between January and February 2021,were analyzed. Those who had SARS-CoV-2 IgG and IgM measurement in the previous two weeks before the CoronoVac vaccine, and those who were both found negative and who had SARS-CoV-2 IgG and IgM measurement after the first dose of CoronaVac vaccine were included in the research. SARS-CoV-2 IgG/IgM were measured by VIDAS® (BioMérieux, Marcy-l'Etoile, France) device for the detection of spike protein specific IgG/IgM of SARS-CoV-2 in human serum with E.. View More»
    DOI: 10.35248/1948-5964.21.s18.004

    Abstract HTML PDF